Related Experiment Video
Updated: May 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Oncolytic effects of a novel influenza A virus expressing interleukin-15 from the NS reading frame
Marijke van Rikxoort1, Martin Michaelis, Markus Wolschek
1Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main, Germany.
Abstract:
Oncolytic influenza A viruses with deleted NS1 gene (delNS1) replicate selectively in tumour cells with defective interferon response and/or activated Ras/Raf/MEK/ERK signalling pathway. To develop a delNS1 virus with specific immunostimulatory properties, we used an optimised technology to insert the interleukin-15 (IL-15) coding sequence into the viral NS gene segment (delNS1-IL-15). DelNS1 and delNS1-IL-15 exerted similar oncolytic effects. Both viruses replicated and caused caspase-dependent apoptosis in interferon-defective melanoma cells. Virus replication was required for their oncolytic activity. Cisplatin enhanced the oncolytic activity of delNS1 viruses. The cytotoxic drug increased delNS1 replication and delNS1-induced caspase-dependent apoptosis. Interference with MEK/ERK signalling by RNAi-mediated depletion or the MEK inhibitor U0126 did not affect the oncolytic effects of the delNS1 viruses. In oncolysis sensitive melanoma cells, delNS1-IL-15 (but not delNS1) infection resulted in the production of IL-15 levels ranging from 70 to 1140 pg/mL in the cell culture supernatants. The supernatants of delNS1-IL-15-infected (but not of delNS1-infected) melanoma cells induced primary human natural killer cell-mediated lysis of non-infected tumour cells. In conclusion, we constructed a novel oncolytic influenza virus that combines the oncolytic activity of delNS1 viruses with immunostimulatory properties through production of functional IL-15. Moreover, we showed that the oncolytic activity of delNS1 viruses can be enhanced in combination with cytotoxic anti-cancer drugs.
Insights
Researchers engineered an oncolytic influenza virus (delNS1-IL-15) that selectively targets tumor cells and stimulates the immune system. This novel virus demonstrates potent anti-cancer activity, enhanced by chemotherapy, offering a promising new cancer therapy.
Area of Science:
- Oncolytic virology
- Immunotherapy
- Cancer research
Background:
- Oncolytic influenza A viruses with a deleted NS1 gene (delNS1) show selective tumor cell replication.
- Tumor cells with defective interferon response or activated Ras/Raf/MEK/ERK pathways are targeted.
- There is a need for oncolytic viruses with enhanced immunostimulatory properties.
Purpose of the Study:
- To develop a delNS1 virus with specific immunostimulatory properties by inserting the interleukin-15 (IL-15) coding sequence.
- To evaluate the oncolytic efficacy and immunostimulatory potential of the engineered virus (delNS1-IL-15).
- To investigate the synergistic effects of delNS1 viruses with cytotoxic drugs and MEK/ERK pathway inhibitors.
Main Methods:
- Optimized technology was used to insert the IL-15 coding sequence into the NS gene segment of delNS1 virus.
- Oncolytic effects were assessed in interferon-defective melanoma cells.
- Virus replication, apoptosis, and IL-15 production were measured.
- Natural killer (NK) cell-mediated lysis of tumor cells was evaluated.
- The impact of cisplatin and MEK/ERK pathway inhibition was studied.
Main Results:
- Both delNS1 and delNS1-IL-15 viruses exhibited similar oncolytic effects and caused caspase-dependent apoptosis in melanoma cells.
- Virus replication was essential for oncolytic activity.
- Cisplatin enhanced delNS1 virus replication and apoptosis induction.
- delNS1-IL-15 infection led to significant IL-15 production in cell culture supernatants.
- Supernatants from delNS1-IL-15-infected cells induced NK cell-mediated lysis of non-infected tumor cells.
Conclusions:
- A novel oncolytic influenza virus (delNS1-IL-15) was constructed, combining oncolytic activity with IL-15-mediated immunostimulation.
- The engineered virus effectively stimulates natural killer cells to lyse tumor cells.
- The oncolytic activity of delNS1 viruses can be potentiated by combination with cytotoxic anti-cancer drugs.
Related Concept Videos
Leaky Scanning
Influenza

